The Rajasthan drug control department has suspended the sale and use of a specific batch of Bupivacaine injection after 16 patients in Hyderabad reportedly suffered serious adverse reactions. The precautionary ban will remain until investigations are complete. Authorities have recalled the affected batch, collected samples for testing, and halted its use across hospitals statewide.